Raymond James Financial Inc. purchased a new position in shares of Global Medical REIT Inc. (NYSE:GMRE - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 185,224 shares of the company's stock, valued at approximately $1,430,000. Raymond James Financial Inc. owned approximately 0.28% of Global Medical REIT as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in GMRE. Zacks Investment Management raised its stake in shares of Global Medical REIT by 12.9% during the third quarter. Zacks Investment Management now owns 14,803 shares of the company's stock valued at $147,000 after purchasing an additional 1,696 shares in the last quarter. Rhumbline Advisers boosted its stake in Global Medical REIT by 2.6% in the 4th quarter. Rhumbline Advisers now owns 108,862 shares of the company's stock worth $840,000 after purchasing an additional 2,731 shares during the period. New York State Common Retirement Fund grew its position in Global Medical REIT by 3.2% during the 4th quarter. New York State Common Retirement Fund now owns 94,158 shares of the company's stock worth $727,000 after purchasing an additional 2,900 shares in the last quarter. SG Americas Securities LLC raised its position in Global Medical REIT by 13.8% during the fourth quarter. SG Americas Securities LLC now owns 25,828 shares of the company's stock valued at $199,000 after buying an additional 3,128 shares during the period. Finally, Redmond Asset Management LLC lifted its position in shares of Global Medical REIT by 2.5% in the fourth quarter. Redmond Asset Management LLC now owns 243,447 shares of the company's stock worth $1,879,000 after purchasing an additional 5,929 shares in the last quarter. Hedge funds and other institutional investors own 57.52% of the company's stock.
Global Medical REIT Price Performance
Shares of GMRE traded down $0.57 on Thursday, hitting $8.03. The company's stock had a trading volume of 670,479 shares, compared to its average volume of 427,568. Global Medical REIT Inc. has a fifty-two week low of $7.33 and a fifty-two week high of $10.46. The company has a 50 day moving average price of $8.40 and a 200 day moving average price of $8.65. The company has a debt-to-equity ratio of 1.26, a current ratio of 0.28 and a quick ratio of 0.28. The company has a market capitalization of $536.64 million, a PE ratio of -401.05, a PEG ratio of 1.43 and a beta of 1.12.
Global Medical REIT (NYSE:GMRE - Get Free Report) last issued its earnings results on Thursday, February 27th. The company reported $0.22 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.01 by $0.21. The firm had revenue of $35.16 million for the quarter, compared to analysts' expectations of $34.87 million. Global Medical REIT had a return on equity of 0.86% and a net margin of 3.23%. On average, research analysts anticipate that Global Medical REIT Inc. will post 0.81 earnings per share for the current fiscal year.
Global Medical REIT Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 9th. Shareholders of record on Friday, March 21st will be given a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a yield of 10.47%. The ex-dividend date of this dividend is Friday, March 21st. Global Medical REIT's dividend payout ratio (DPR) is presently 8,400.00%.
Analyst Upgrades and Downgrades
Separately, B. Riley began coverage on shares of Global Medical REIT in a research report on Thursday. They issued a "neutral" rating and a $9.00 target price for the company.
Get Our Latest Report on GMRE
Global Medical REIT Profile
(
Free Report)
Global Medical REIT Inc (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.
Further Reading
Before you consider Global Medical REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Global Medical REIT wasn't on the list.
While Global Medical REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
